Background and Objective: Periodontal ligament stem cells (PDLSCs) from the periodontal ligament tissue were recently identified as mesenchymal stem cells (MSCs). The capabilities of PDLSCs in periodontal tissue or bone regeneration have been reported, but their immunomodulatory role in T-cell immune responses via dendritic cells (DCs), known as the most potent antigen-presenting cell, has not been studied. The aim of this study is to understand the immunological function of homogeneous human STRO-1 + CD146 + PDLSCs in DC-mediated T-cell immune responses to modulate the periodontal disease process.
Material and Methods:
We utilized highly purified (> 95%) human STRO-1 + CD146
+ PDLSCs and human bone marrow mesenchymal stem cells (BMSCs). Each stem cell was co-cultured with human monocyte-derived DCs in the presence of lipopolysaccharide isolated from Porphyromonas gingivalis, a major pathogenic bacterium responsible for periodontal disease, in vitro to examine the immunological effect of each stem cell on DCs and DC-mediated T-cell proliferation.
Results:
We discovered that STRO-1 + CD146
+ PDLSCs, as well as BMSCs, significantly decreased the level of non-classical major histocompatibility complex glycoprotein CD1b on DCs, resulting in defective T-cell proliferation, whereas most human leukocyte antigens and the co-stimulatory molecules CD80 and CD86 in/on DCs were not significantly affected by the presence of BMSCs or STRO-1 + CD146 + PDLSCs. Mesenchymal stem cells (MSCs), first discovered in 1968, have been noted for being capable of multipotent differentiation into various cell types and for applicability in the repair of injured tissue in regenerative medicine (1, 2) . MSCs have also been recognized for their essential role in immunomodulation in preventing immune-related complications such as graft vs. host disease, and thus their therapeutic potential is of interest to many researchers (3) . MSCs were originally identified in bone marrow, and have been found in other organs, such as lung, liver and spleen, suggesting the potential of MSCs to be utilized in a variety of tissue-related diseases (4, 5) .
Conclusions
Recently, periodontal ligament stem cells (PDLSCs), newly identified MSCs, were found in the periodontal ligament tissue. Several studies reported the ability of PDLSCs to regenerate periodontal tissue and bone (6, 7) , as well as their immunomodulatory effect on allogenic and xenogeneic peripheral blood mononuclear cell immune responses (8, 9) or on allogenic T cells (10) . PDLSCs are easily obtained, relative to other MSCs, as they can be obtained from extracted teeth during routine dental care, increasing their potential as a promising new tool in stem cell therapy for immune regulation. It has been reported that PDLSCs express MSC markers STRO-1 and CD146 (11) , and the proportion of homogeneous STRO-1 + CD146 + MSCs among heterogeneous populations of PDLSCs ranges from 10 to 53% depending on the types of cell detaching methods (10, 12, 13) ; however, there is a lack of studies regarding the immunomodulatory roles of STRO-1 +
CD146
+ PDLSCs. The classical major histocompatibility complex (MHC), referred to as human leukocyte antigen (HLA) in humans, consists of more than 200 genes encoding 40 different leukocyte antigens specialized in presenting fragments of proteins (14, 15) . Nonclassical MHC-like glycoproteins known as the CD1 family, consisting of the CD1a, CD1b, CD1c, CD1d and CD1e molecules, also have an important function in presenting unique microbial lipids and glycolipids, thereby activating CD1-restricted T-cell immune responses against mycobacterial infection (16) (17) (18) . These MHC and MHC-like molecules are widely expressed on antigen presenting cells, and dendritic cells (DCs) are the most potent antigen presenting cells specialized in inducing antigen-specific T-and B-cell adaptive immune responses.
DCs act as immune initiators and regulators in inducing antigen-specific immune responses. Upon exposure to self or harmless antigens, immature DCs (ImDCs) suppress immune responses, but in the case of pathogenic antigens, they become mature DCs (mDCs) and induce antigen-specific T-cell responses (19, 20) . Of the several CD4 + T-cell subsets, activated T-helper (Th)1 and Th17 cells have been reported to be closely associated with the induction of bone destruction via osteoclastogenesis (21) , indicating the importance of understanding how PDLSCs regulate DCmediated T-cell immune responses potentially to treat T-cell-mediated periodontal disease.
It has been reported that bone marrow mesenchymal stem cells (BMSCs) inhibited the differentiation of monocytes into DCs, as well as subsequent DC maturation, resulting in defective T-cell immune responses (22, 23 PDLSCs from the tooth were isolated as previously described (27) . All PDLSCs cultured for five to seven passages were utilized, as the stem cell properties of PDLSCs are well maintained up to passage 8, as has been previously reported (27 PDLSCs were seeded on a six-well plate at 5 9 10 5 cells/well 12 h before the day of co-culture. ImDCs (1 9 10 6 ) were cultured only with 100 ng/mL LPS-PG and became mDC only used as a control group, or 1 9 10 6 ImDCs were co-cultured either with BMSCs or STRO-1 + CD146 + PDLSCs in the presence of 100 ng/mL LPS-PG. Two days after the co-culture, the floating mDCs from each co-culture were isolated for further analysis. We designated the purified mDCs that had been formerly co-incubated with either BMSCs or STRO-1 + CD146 + PDLSCs in the presence of LPS-PG as mDC-BM or mDC-PD, respectively (Fig. 1B) .
Mixed lymphocyte reaction assay
Mixed lymphocyte reaction (MLR) assay was performed to induce allogenic T-cell proliferation. Allogenic T cells proliferate as they recognize foreign peptide loaded-MHC complexes on DCs (28) . To examine T-cell proliferation, carboxyfluorescein succinimidyl ester (CFSE; Invitrogen) assay was utilized, and its intensity decreases as CFSE-stained allogenic T cells proliferate (29) . CD3 + T cells were isolated from white blood cells using a pan-T-cell isolation cocktail kit (Miltenyi Biotec) and MACS and then labeled with CFSE. We utilized two different MLR assays, stem cell direct or indirect MLR assay, as described in Fig 
Microarray
We isolated total RNA from the purified DCs, from two (mDC only) and three (mDC-BM or mDC-PD) independent samples, using an RNeasy mini kit (Qiagen, Valencia, CA, USA). We then assessed RNA integrity using a Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA). RNA integrity was in the range of RIN = 9.8-10 for all samples. RNA was reverse-transcribed, amplified and then hybridized to an Agilent-039,494 SurePrint G3 Human GE v2 8 9 60 K array, including 62,976 probes corresponding to 23,270 annotated genes, following Agilent's standard protocols. The fluorescent signal on the array was measured using an Agilent SureScan microarray scanner (Agilent Technologies). The probe intensities were converted to log 2 intensities and then normalized using the quantile normalization method (30) . The normalized data were deposited in the GEO database (GSE68286).
Statistical analysis of gene expression data
Using the normalized log 2 intensities, differentially expressed genes (DEGs) between the two conditions (mDC-BM vs. mDC only or mDC-PD vs. mDC only) were identified as previously described (31) . Briefly, (i) Student's t-test was performed to compute T values for all genes; (ii) empirical distribution of the null hypothesis was estimated by performing all possible combinations of random permutations of samples and then applying the Gaussian kernel density estimation method to T values resulting from the random permutations (31); (iii) adjusted p-value of each gene was computed by the twotailed test using the empirical distribution; and (iv) DEGs were identified as genes present with an adjusted p < 0.05. To reduce false positives, we further selected the DEGs as those genes whose absolute log 2 -foldchanges were larger than 0.58 (1.5-fold). Finally, gene ontology biological processes (GOBPs) enriched by lists of genes were identified as those with p < 0.05 using DAVID software (32) .
CD1b siRNA treatment to immature dendritic cells
ImDCs were cultured either with 10 nM CD1b siRNA (Sigma) in Lipofectamine RNAiMAX (Invitrogen) or Lipofectamine RNAiMAX alone (vehicle) in the presence of 100 ng/mL LPS-PG. Two days after the treatment, the expression level of CD1b on the DCs was measured by flow cytometry.
Flow cytometry
Cells were washed with fluorescenceactivated cell sorting (FACS) buffer (FBS 2% in phosphate-buffered saline) twice, and then stained with antibodies at 4°C for 30 min. Data were acquired with a FACSCalibur or BD LSR Fortessa (BD Biosciences, San Jose, CA, USA) and analyzed with FlowJo software (Tree Star Inc., Ashland, OR, USA). Median fluorescence intensity data were shown after subtraction of the corresponding isotype control value. The used antibodies were as follows: CD11c (B-ly6), CD80 (L307.4), CD83 (HB15e), CD86 (IT2.2), HLA-DR (TU36) and CD3 (HIT3a) were purchased from BD Biosciences; CD1a (HI149), CD1c (L161) and mouse IgG1 (MOPC-21) were purchased from BioLegend (San Diego, CA, USA); CD1b (17-0018) and rat IgG2a were purchased from eBioscience (San Diego, CA, USA).
Quantitative reverse transcriptionpolymerase chain reaction analysis

CD3
+ T cells that had been co-cultured with mDC only, mDC-BM or mDC-PD were isolated by MACS. Total RNA was extracted with Trizol (Invitrogen), and cDNA was synthesized with a cDNA synthesis kit (NEB, Ipswich, MA, USA). A Light Cycler 480 II (Roche, Clovis, CA, USA) was utilized to perform SYBR Green-based quantitative reverse transcriptionpolymerase chain reaction (qRT-PCR). The house-keeping gene, GAPDH, was used for normalization. Fig. 2A) . We administered various concentrations of LPS-PG to ImDCs to determine its optimal concentration for stimulating ImDCs to become mDCs, and found 100 ng/mL LPS-PG to be ideal based on the highly expressed co-stimulator CD80, CD83, CD86 and HLA-DR markers (Fig. 2B) . To examine the immune suppressive role of BMSCs or STRO-1 + CD146
+ PDLSCs in T-cell proliferation, we performed two different allogenic MLR assays, stem cell direct or indirect MLR assay as described in Fig. 1 (Fig. 2C) . Interestingly, the suppressed levels of T-cell proliferation between STRO-1 + CD146
+ PDLSC direct and indirect MLR assays were comparable (Fig. 2C) + PDLSCs on the status of DC maturation in the presence of LPS-PG, as the data showed that maturation markers on mDC-BM and mDC-PD were highly expressed and comparable to those expressed on mDC only, although CD83 and HLA-DR expressions on mDC-BM were somewhat decreased when compared with those expressed on mDC only (Fig. 3A,B) . Interestingly, despite the expressions of DC maturation markers not being altered on mDC-PD, in the indirect MLR assay with the ratio of 1-5 (mDC-BM or mDC-PD to T cells), we again confirmed that T-cell proliferation induced by mDC-PD was significantly decreased compared with that induced by mDC only, and its decreased level was comparable to the decreased level of T-cell proliferation induced by mDC-BM (Fig. 3C,D) .
The non-classical major histocompatibility complex-like glycoprotein CD1b was downregulated in mDCs influenced by bone marrow mesenchymal or periodontal ligament stem cells
We then screened factors in mDC-BM or mDC-PD that might cause decreased T-cell proliferation by profiling gene expression in mDC only, mDC-BM and mDC-PD, using Agilent SurePrint G3 Human GE v2, and compared mDC-BM or mDC-PD with mDC only (mDC-BM vs. mDC only, or mDC-PD vs. mDC only). We identified a total of 1444 DEGs that comprise 998 and 1286 genes from mDC-BM vs. mDC only and mDC-PD vs. mDC only, respectively ( Fig. 4A and Table S1 ). To explore these DEGs systematically, we first categorized the 1444 DEGs into seven clusters (C1-C7) based on their up-and downregulation patterns in the two comparisons ( Fig. 4B and Table S2 ). The decreased T-cell proliferation primed either by mDC-BM or mDC-PD suggests that genes showing shared differential expression in the two DCs might be responsible for the decreased T-cell proliferation. Thus, we focused on C1 and C7, which shared up-and downregulation, respectively, in both mDC-BM and mDC-PD. To reveal the cellular processes regulated by the genes in these clusters, we then performed enrichment analysis of GOBPs for the genes in C1 and C7 using DAVID software (32) . Processes related to apoptosis and cell cycle were primarily represented in C1 (Fig. 4C) , and processes related to foreign lipid presentation, such as lipid metabolism and endosomal networks, were represented in C7 (Fig. 4C) . Interestingly, the C7 data suggested decreased foreign lipid presentation, which may be associated with the decreased T-cell proliferation induced by mDC-BM and mDC-PD. To compare alterations in lipid presentation and/or peptide presentation in mDC-BM and mDC-PD, we examined the differential expression of non-classical MHC-like glycoproteins, CD1 genes, for lipid presentation and of classical HLA molecules for peptide presentation. The CD1a and CD1b genes were significantly downregulated in both mDC-BM and mDC-PD, whereas expression of CD1d and most HLA molecules had no significant differences between the groups (Fig. 4D) . These data, together with the enrichment analysis of GOBPs, strongly suggest that alterations in CD1 gene expression in DCs may account for the decreased T-cell proliferation.
To confirm further the expression levels of CD1a, CD1b and CD1c genes in mDC-BM and mDC-PD, but not of the intracellularly expressed CD1e gene (35), we performed qRT-PCR and flow cytometric analyses. By mRNA analysis, we observed dramatically decreased expressions of CD1a, CD1b and CD1c in both mDC-BM and mDC-PD compared with those in mDC only (Fig. 5A) . Interestingly, the mRNA expression levels of CD1b and CD1c in mDC-PD were even lower than those in mDC-BM (Fig. 5A) . However, by protein expression analysis, we only observed a significant decrease in CD1b on mDC-BM and mDC-PD compared with that on mDC only, and found no difference in the level of CD1b expression between mDC-BM and mDC-PD (Fig. 5B) .
The decreased expression of CD1b on mature dendritic cells results in suppressed T-cell proliferation
As we observed significant decreases in T-cell proliferation induced by mDC-BM or mDC-PD compared with that induced by mDC only, and as we found significantly decreased expression of CD1b on both mDC-BM and mDC-PD, we treated DCs with CD1b siRNA to examine the role of CD1b expression in mDCs in priming T cells. The expression of CD1b on CD1b siRNA-treated mDCs was significantly decreased (Fig. 6A) , and the decreased expression of CD1b on mDC by CD1b siRNA treatment was comparable to that on mDC-BM or mDC-PD (Fig. 6B) . We then co-cultured mDCs that had been formerly treated with CD1b siRNA with na€ ıve CD3 + T cells, and found decreased T-cell proliferation compared with that induced by vehicle-treated mDCs (Fig. 6C,D) . Interestingly, the decreased level of Tcell proliferation induced by mDCs that had been formerly treated with CD1b siRNA was comparable to that induced by mDC-BM or mDC-PD (Fig. 6E) . Taken 
Discussion
Immune regulation is a primary factor to be considered in utilizing MSCs therapeutically, and in most cases, DCs have a pivotal role in regulating T-cell adaptive immunity. The importance of regulating T-cell immune responses in periodontal disease has been described more than one decade ago, demonstrating the mice are resistant to bacteria-induced alveolar bone loss in the absence of CD4 + T cells (36) . In addition, several studies demonstrated that the enhanced number of DCs such as Langerhans or interstitial DCs is recruited into the diseased periodontal tissues (37) (38) (39) , where later DCs induce antigen-specific T-cell immune responses responsible for the induction of periodontal disease (40) . The immunomodulatory role of PDLSCs in DCs, the main immune regulator (19), has not been described. In this study, we demonstrated that human BMSCs and STRO-1 + CD146 + PDLSCs successfully reduced the expression of a nonclassical MHC-like glycoprotein, CD1b, on mDCs, resulting in significantly decreased T-cell proliferation.
Expressions of MHCs (HLAs in humans) and co-stimulators are critical to stimulate T-cell immune responses (33, 34) . Interestingly, unlike previous studies demonstrating the inhibitory role of BMSCs in DC differentiation and maturation (22, 23) , we did not observe significant decreases in maturation markers or other classical HLAs on either mDC- BM or mDC-PD, except for slightly decreased CD83 and HLA-DR on mDC-BM, compared with levels of those expressed on mDC only ( Fig. 3B and 4D ). We reasoned that the dosage of LPS-PG given to DCs at least to mimic the physiological conditions of periodontal disease might provide a saturated signal for DC maturation. In addition, as P. gingivalis is commonly present in periodontal disease, and lipid A from LPS-PG can be presented via CD1b and CD1c molecules on DCs to elicit cd T-cell immune responses (41); in such pathological conditions, the immunological role of CD1b may be more specifically regulated by MSCs than are other well-known HLAs. However, in the case of mDC-BM, as the expressions of co-stimulator CD83 and HLA-DR on mDC-BM were somewhat decreased, these decreases may also provide a role in the decreased T-cell proliferation. Further studies are required to understand whether the levels of MSC mediated factors such as IL-6, IL-10 and prostaglandin E 2 , inhibiting DC maturation (42, 43) Although we observed dramatically decreased mRNA expression levels of CD1a, CD1b and CD1c in both mDC-BM and mDC-PD compared with those levels in mDC only, in protein analysis, we found that only the CD1b level was significantly decreased on mDC-BM and mDC-PD. In addition, the decreased level of CD1b on mDC-BM and mDC-PD seen via protein analysis was much lower than that seen via mRNA analysis. One possible explanation may be the recycling pathway of CD1 proteins, which are repeatedly internalized and exposed to the plasma membrane as they present lipid antigens (44, 45) .
Decreased expression of CD1b on mDCs driven by CD1b siRNA treatment, comparable to the decreased levels of CD1b expression on mDC-BM and mDC-PD, was sufficient to result in decreased T-cell proliferation, again similar to the decreased level of T-cell proliferation induced by mDC-BM or mDC-PD, suggesting the important role of CD1b expression on mDCs in priming T-cell immune responses. Such importance of CD1b in mDCs in T-cell induction is supported by a previous study demonstrating that defective CD1b structure results in decreased T-cell immune responses (46) , and is supported by a study showing that CD1b-restricted T-cell immune responses were generated against mycobacteria (47) .
It has been reported that the enhanced lymphocyte activation such as Th1 or Th17 cells are closely related to the induction of periodontitis, while Th2 and regulatory T cells are known to protect it (21, 48) . On the contrary, interferon-c secreted from Th1 cells is known to inhibit the formation of osteoclastogenesis pre- venting periodontitis, whereas Th2-dependent B-cell immune responses promote osteoclastogenesis, indicating the complexity of lymphocyte immune responses in regulating periodontal disease (21, 48 
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